John W. Childs, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), bought 6,644 shares at $59.25 ($394K) on 2020-09-21, disclosed to the SEC on 2020-09-22.
Open-market purchase of $394k BHVN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.25 | 3,322 | $197K | 50.0% |
| 2 | $59.25 | 3,322 | $197K | 50.0% |
| Total | $59.25 avg | 6,644 | $394K | 100% |
| Filing → |
| MANE | BUY | 2026-02-05 | $5.0M | — | Filing → |
| BHVN | BUY | 2025-11-17 | $50.0M | — | Filing → |
| BHVN | BUY | 2025-03-05 | $892K | — | Filing → |